Bio-Techne Corp (TECH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 73,400 | 168,105 | 285,442 | 263,099 | 139,585 |
| Depreciation Amortization | 109,903 | 111,711 | 107,238 | 101,069 | 87,747 |
| Income taxes - deferred | -51,107 | -39,447 | -29,567 | 6,816 | -27,431 |
| Accounts receivable | 34,132 | -20,533 | -20,867 | -57,596 | -15,549 |
| Accounts payable and accrued liabilities | -13,954 | 25,769 | -7,908 | 12,741 | 19,091 |
| Other Working Capital | 11,539 | -10,106 | -90,577 | -69,517 | 29,263 |
| Other Operating Activity | 123,643 | 63,482 | 10,632 | 68,660 | 119,458 |
| Operating Cash Flow | $287,556 | $298,981 | $254,393 | $325,272 | $352,164 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,085 | 22,557 | 14,736 | -26,943 | 26,693 |
| PPE Investments | -31,006 | -62,877 | -38,244 | -44,908 | -44,301 |
| Net Acquisitions | N/A | -169,707 | -101,184 | N/A | -225,352 |
| Purchase Of Investment | -15,000 | 0 | 0 | -25,000 | -556 |
| Sale Of Investment | 0 | 0 | 91,043 | 0 | 0 |
| Other Investing Activity | 9,738 | 6,997 | -232,000 | 0 | 0 |
| Investing Cash Flow | $-35,183 | $-203,030 | $-265,649 | $-96,851 | $-243,516 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 104,000 | 225,000 | 619,661 | 90,000 | 256,000 |
| Debt Repayment | -77,000 | -256,000 | -525,661 | -175,500 | -271,500 |
| Common Stock Issued | 51,739 | 60,935 | 29,813 | 77,155 | 65,092 |
| Common Stock Repurchased | -275,731 | -80,042 | -19,562 | -160,950 | -43,178 |
| Dividend Paid | -50,391 | -50,419 | -50,285 | -50,185 | -49,622 |
| Other Financing Activity | -6,522 | -21,872 | -31,350 | -23,373 | -19,343 |
| Financing Cash Flow | $-253,905 | $-122,398 | $22,616 | $-242,853 | $-62,551 |
| Exchange Rate Effect | 11,927 | -2,333 | -3,356 | -12,092 | 6,369 |
| Beginning Cash Position | 151,791 | 180,571 | 172,567 | 199,091 | 146,625 |
| End Cash Position | 162,186 | 151,791 | 180,571 | 172,567 | 199,091 |
| Net Cash Flow | $10,395 | $-28,780 | $8,004 | $-26,524 | $52,466 |
| Free Cash Flow | |||||
| Operating Cash Flow | 287,556 | 298,981 | 254,393 | 325,272 | 352,164 |
| Capital Expenditure | -31,006 | -62,877 | -38,244 | -44,908 | -44,301 |
| Free Cash Flow | 256,550 | 236,104 | 216,149 | 280,364 | 307,863 |